Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Large intestine osmotic gradient" is **not a specific molecule, receptor, enzyme, transporter, or canonical therapeutic target**. Instead, it refers to the physiological process by which the large intestine absorbs water from intestinal contents through the creation and maintenance of an osmotic gradient across the colonic epithelium[1][5][7]. This process is essential for transforming liquid chyme into semi-solid feces and maintaining body fluid balance. The mechanism involves **active transport of sodium ions (Na+)** from the lumen into intercellular spaces by epithelial cells lining the colon. This increases local osmolarity in these spaces, creating a hypertonic environment that draws water out of the intestinal lumen via osmosis—even when this means moving water against an overall concentration gradient between lumen and blood[1][5][7]. The process is sometimes called "standing gradient osmosis"[5]. This function is critical for normal stool formation; disruption can result in either excessive water retention (diarrhea) or excessive absorption (constipation)[3][7]. However, since "large intestine osmotic gradient" describes a physiological phenomenon rather than a discrete molecular entity or druggable target, it does not have standard aliases, abbreviations, interacting drugs, mechanisms of action for drugs targeting it directly, nor established biomarkers. In summary: > The "large intestine osmotic gradient" refers to how sodium ion pumping by colonic epithelial cells creates localized hypertonicity that drives passive water reabsorption from fecal material—an essential step in forming solid stool and maintaining hydration status. It is not itself a molecular target but rather describes an emergent property resulting from coordinated activity of various ion channels and transporters within large intestinal tissue[1][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Large intestine osmotic gradient.